Robert Huber

Robert Huber

1989 Nobel Prize in Chemistry

Robert Huber is a German biochemist. In 1988, he was awarded the Nobel Prize in Chemistry with Johann Deisenhofer and Hartmut Michel "for the determination of the three-dimensional structure of a photosynthetic reaction centre.

Education and Work Experience
  • 1963, Dr. rer. nat., Technical University of Munich
  • 1976, Apl. Professor, Technical University of Munich
  • 1972-2005, Scientific Member of the Max Planck Society and Director at the Max Planck Institute of Biochemistry
  • 2005-Present, Professor, Cardiff University
Honors and Awards
    • 1988, Nobel Prize in Chemistry
    • 1992, Sir Hans Krebs Medal, Federation of European Biochemical Societies
    • 1999, Foreign Member of the Royal Society (ForMemRS)
    • 2014, Xu Guangqi Medal, SIBS, Shanghai, China
Major Academic Achievements

Robert Huber is known for his work crystallizing an intramembrane protein important in photosynthesis and subsequently applying X-ray crystallography to elucidate the protein's structure. Huber has made major contributions to the understanding of the structure and function of biological macromolecules. He has studied proteases and their natural and synthetic inhibitors, metalloenzymes (iron, nickel, molybdenum, copper), proteins of the immune system (antibodies and antibody receptors), protein hormones and their receptors, protein kinases, enzymes of amino acid biosynthesis, enzymes of cofactor and vitamin biosynthesis and proteins of energy and electron transfer. In addition, he has contributed to the development of instruments for data collection and to methods in protein crystallography, particularly Patterson methods, graphic methods, and refinement, to the use of electron rich metal clusters, and most recently to the methods and instruments for crystal improvement. He is co-founder of two companies, Proteros and Suppremol, located in Martinsried and offering services for drug discovery and development and for the development of novel therapies for autoimmune diseases, respectively.